| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5678830 | European Journal of Internal Medicine | 2017 | 8 Pages |
Abstract
Novel cardiovascular biomarkers such as ST2, GDF-15, uPAR and H-FABP could offer a great potential for more precise diagnostic in ICM and DCM patients. H-FABP was the most promising marker in our study, followed by sST2, uPAR and GDF-15. Additional prospective studies will be necessary to further evaluate the potential clinical benefits in routine treatment of HF.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Michael Lichtenauer, Peter Jirak, Bernhard Wernly, Vera Paar, Ilonka Rohm, Christian Jung, Christiana Schernthaner, Johannes Kraus, Lukas J. Motloch, Atilla Yilmaz, Uta C. Hoppe, P. Christian Schulze, Daniel Kretzschmar, Rudin Pistulli,